NIH #3K22CA258805-04S1
Targeted disruption of the YAP/TAZ/TEAD axis in pancreatic cancer
- Amount
- $76K
- Period
- 2024-02-01 → 2024-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at FRED HUTCHINSON CANCER CENTER
Full Professor(heuristic)
Protein Degradation and Inhibitors · Molecular Biology
h-index34
i10-index45
Publications132
Citations8,481
Grants
5 total · 0 active
NIH #5K22CA258805-04
Targeted disruption of the YAP/TAZ/TEAD axis in pancreatic cancer
- Amount
- $189K
- Period
- 2021-09-01 → 2024-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at FRED HUTCHINSON CANCER CENTER
NIH #5K22CA258805-03
Targeted disruption of the YAP/TAZ/TEAD axis in pancreatic cancer
- Amount
- $189K
- Period
- 2021-09-01 → 2024-08-31
- PIs
- 1
- Est. capacity / PI
- ~0 students
Awarded at FRED HUTCHINSON CANCER CENTER
Student capacity is a rough estimate from remaining award size, split equally among PIs. Actual funding decisions vary.
Career Trajectory
Research Cluster Map
Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.
Potential Collaborators
Recent Publications
Last 2 years · showing 2 of 2Nature Communications · 2025-01-02 · 34 citations
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer models
Journal of Clinical Investigation · 2024-12-24 · 16 citations